Overview

Regulation of Lipoprotein Transport in Metabolic Syndrome

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether PPAR-delta agonist (GW5015156)had favorable effect on lipoprotein metabolism.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Western Australia
Collaborator:
National Heart Foundation, Australia